Genitourinary system, also referred as urogenital system, includes both reproductive organs and urinary system. In genitourinary system, urology deals with study or complications associated with entire urinary system where as nephrology is associated with only kidneys. Genitourinary drugs market is witnessing growth due to increasing incidences of urinary diseases.
Broadly, genitourinary drugs are referred as urologicals, gynaecologicals, sex hormones and genitourinary anti-infectives. Urologicals are antiseptic preparations used to treat infections related to urinary tract, whereas gynaecologicals are utilised for treatment of diseases related to females. Another type of drugs which is gaining traction is sex hormones which are generally steroids used for functioning and growth of reproductive organs. Sex hormone controls the largest market share, whereas genitourinary anti-infectives are expected to witness the highest growth due to rising incidences of urinary tract infections (UTIs).
In addition to therapeutics, urology and nephrology devices comprises major share of the overall genitourinary market. These devices are generally used for diagnosis and treatment of disorders related to both male and female urinary systems and male reproductive organs. Currently used urology devices are minimally invasive and they are used for surgical management of medical conditions such as prostate enlargement, urinary tract infections and cancers associated with urinary bladder and prostate.
By geography, North America is the largest market. Globally, Asia Pacific is expected to show the highest growth rate owing to increasing disposable income and rising cases of urological complexities and cancers related to genitourinary system.
Higher incidence of urinary infections, increasing urinary incontinence and impotency concerns, technologic advancements and increasing awareness amongst the population are some of the driving factors for genitourinary drugs and devices market.
ASDReport.com has an extensive repository of reports on genitourinary market. These reports cover various therapeutics and diagnostics related to genitourinary market like end-stage kidney disease, polycystic kidney disease, renal denervation, renal cancer treatment, prostate cancer, kidney dialysis equipment, kidney fibrosis and much more.